About Us
Apple Tree Partners, founded in 1999, creates life sciences companies.
Through two predecessor funds, Apple Tree founded and built Aileron Therapeutics, Gloucester Pharmaceuticals (acquired by Celgene), HeartWare International (NASDAQ:HTWR) and Tokai Pharmaceuticals.
The firm has closed a major new partnership, the entirety of which it will use to invest in Apple Tree Consolidated, a holding company that will create and own complementary life sciences businesses (pharmaceuticals, medical devices, and technology-enabled healthcare services). Upon approval, the Apple Tree Consolidated division Braeburn Pharmaceuticals will market Probuphine, a breakthrough therapy for opioid addiction.
